Spoken Alpha
Ascend Wellness Holdings, Inc.
Ascend Wellness Holdings operates as a vertically integrated cannabis company that cultivates, manufactures, and distributes cannabis products across seven U.S. states through company-owned retail dispensaries, retail partner locations, and wholesale customers.
Ascend Wellness Holdings, Inc is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $92.0M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 5, 2026).
20 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Spoken Alpha tracks AAWH's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 70% positive reaction rate
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for AAWH.
$ curl https://api.spokenalpha.com/v1/companies/AAWHFAQ
Spoken Alpha indexes AAWH's earnings call transcripts at https://spokenalpha.com/companies/AAWH. Each call links to attributed speakers and parsed analyst Q&A. Ascend Wellness Holdings, Inc.'s own investor relations page is at https://investors.awholdings.com/news-events/events-and-materials.
Ascend Wellness Holdings, Inc. (AAWH) held its most recent earnings call on 2026-05-13, covering fiscal Q1 2026.
Ascend Wellness Holdings, Inc. (AAWH) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-05 | — | $-0.15 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-05-12 | $0.00 | $-0.16 | +100.0% | — | — | — | EODHD |
| Q3 FY2025 | 2025-11-09 | $-0.13 | $-0.10 | -30.0% | $124.7M | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $-0.12 | $-0.07 | -71.4% | $127.3M | — | — | EODHD |
| Q1 FY2025 | 2025-05-11 | $-0.09 | $-0.07 | -28.6% | $128.0M | — | — | EODHD |
| Q4 FY2024 | 2025-03-11 | $-0.08 | $-0.10 | +20.0% | $136.0M | — | — | EODHD |
| Q3 FY2024 | 2024-11-11 | $-0.13 | $-0.09 | -44.4% | $141.6M | — | — | EODHD |
| Q2 FY2024 | 2024-08-04 | $-0.10 | $-0.07 | -42.9% | $141.5M | — | — | EODHD |
| Q1 FY2024 | 2024-05-06 | $-0.09 | $-0.06 | -50.0% | $142.4M | — | — | EODHD |
| Q4 FY2023 | 2024-03-11 | $-0.09 | $-0.07 | -28.6% | $140.2M | — | — | EODHD |
| Q3 FY2023 | 2023-11-06 | $-0.05 | $-0.08 | +37.5% | $141.3M | — | — | EODHD |
| Q2 FY2023 | 2023-08-07 | $0.00 | $-0.09 | +100.0% | $123.0M | — | — | EODHD |
| Q1 FY2023 | 2023-05-08 | $-0.10 | $-0.05 | -100.0% | $114.2M | — | — | EODHD |
| Q4 FY2022 | 2023-03-13 | $-0.08 | $-0.04 | -100.0% | $112.1M | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $-0.09 | $-0.05 | -80.0% | $111.2M | — | — | EODHD |
| Q2 FY2022 | 2022-08-14 | $-0.11 | $-0.06 | -83.3% | $97.5M | — | — | EODHD |
| Q1 FY2022 | 2022-05-10 | $-0.13 | $-0.03 | -100.0% | $85.1M | — | — | EODHD |
| Q4 FY2021 | 2022-03-07 | $-0.10 | $-0.00 | -100.0% | $88.5M | — | — | EODHD |
| Q3 FY2021 | 2021-11-10 | $-0.08 | $0.02 | -100.0% | $94.4M | — | — | EODHD |
| Q2 FY2021 | 2021-08-09 | $-0.30 | $0.01 | -100.0% | $83.4M | — | — | EODHD |
Source: EODHD. AAWH reported actuals as published; sparse fields render as —.
Consistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.59 | $3.84 | +19.6% | -1.6% | -1.7% |
| Q4 FY2026 | $4.95 | $3.89 | +27.2% | +0.7% | +0.4% |
| Q3 FY2026 | $4.46 | $3.77 | +18.3% | +0.9% | -0.4% |
| Q2 FY2026 | $5.06 | $3.91 | +29.5% | +0.9% | +3.2% |
| Q1 FY2025 | $5.11 | $4.00 | +27.7% | +3.9% | +5.4% |
| Q4 FY2025 |
| $4.79 |
| $3.78 |
| +26.7% |
| +1.3% |
| +3.6% |
| Q3 FY2025 | $4.52 | $3.78 | +19.6% | +2.7% | +2.9% |
| Q2 FY2025 | $5.08 | $3.95 | +28.5% | +5.1% | +5.4% |
| Q1 FY2024 | $5.15 | $4.05 | +27.1% | -4.6% | -5.8% |
| Q4 FY2024 | $5.06 | $3.92 | +29.1% | -1.9% | +0.9% |